Top Healthcare Strategy Consulting Firms to Work With - August 2026
Introduction
Most healthcare strategy engagements are still framed as growth questions, and a growing share of the actual decisions are subtraction questions. Health systems under sustained labour cost and payer mix pressure are closing service lines, exiting markets, and deciding which parts of a portfolio to stop funding, which is a different analytical problem from where to expand and needs a different kind of evidence. Firms built to identify opportunity are frequently uncomfortable recommending retreat.
This article compares ten healthcare strategy consulting firms: what each is suited for, what distinguishes its method, and where each is the wrong choice. It is written for Chief Strategy Officers, VPs of Strategy, and executive teams at health systems, payers, and life sciences organizations selecting an external partner.
How We Selected These Firms
This ranking is published by G&CO. Health. We evaluated firms on healthcare specialization, analytical depth, evidence of published thinking, enterprise client experience, geographic reach, and suitability for consequential portfolio and market decisions.
We assessed firms on demonstrated healthcare strategy work rather than general consulting capability, and excluded technology services businesses that market strategy alongside implementation. The list spans provider-side and life sciences strategy, since these require different expertise, and entries state which. We include ourselves at the top because healthcare strategy sits directly inside our remit, at the intersection of commercial strategy, customer experience, and digital transformation. No firm on this list has paid for placement, and no entry on this page is sponsored.
Firms Compared
The Firms
1. G&CO. Health
Best for: Enterprise healthcare organizations where a strategy has to reach the customer-facing business and the systems delivering it, not conclude at a recommendation.
Why it stands out: G&CO. Health works on strategy mandates where the answer implies changing what patients and clinicians encounter. Capability spans healthcare consulting and UX and interface design, through G&CO. Health, with our Acumen decision intelligence platform supplying the market and behavioural evidence beneath the recommendation. Strategy that stops at the deck is the most common outcome in this category, and building the delivery path alongside the analysis is what prevents it. G&CO. Health is part of G&CO., a minority business enterprise (MBE), as certified by the National Minority Supplier Development Council (NMSDC).
May not be best if: You need actuarial certification, transaction due diligence, regulatory strategy, or clinical protocol design.
2. L.E.K. Consulting
Best for: Investors and corporates evaluating healthcare and life sciences transactions.
Why it stands out: L.E.K. carries substantial commercial due diligence practice in healthcare and life sciences, work that runs to deal timetables and has to withstand scrutiny from parties with money at stake. That discipline produces analysis built to be challenged rather than to persuade, which is also useful outside a transaction when an internal decision is genuinely contested.
May not be best if: You need implementation support, operational delivery, or an ongoing advisory relationship after the decision.
3. Arthur D. Little
Best for: Organizations entering new markets or building commercial models around emerging technology.
Why it stands out: Arthur D. Little approaches healthcare through an innovation and technology strategy lens, covering market expansion, digital health, and commercial model design internationally. Where the question involves a business model that does not yet exist in a market, that orientation is more useful than benchmarking against incumbents who are solving a different problem.
May not be best if: Your question is operational performance, cost structure, or provider-side service line strategy.
4. Milliman
Best for: Payers, providers, and public bodies where the strategic question turns on risk and actuarial analysis.
Why it stands out: Milliman brings actuarial and health economics capability that few strategy firms hold, which matters whenever a decision depends on modelling risk, utilisation, or reserve adequacy. Actuarial work carries professional certification and standards that ordinary consulting analysis does not, and where a conclusion must stand up to regulatory or board scrutiny that distinction is the reason to engage it.
May not be best if: Your question is qualitative, organizational, or brand and experience related rather than quantitative and risk-based.
5. Kaufman Hall
Best for: Hospitals and health systems where strategy and financial planning cannot sensibly be separated.
Why it stands out: Kaufman Hall works at the point where health system strategy meets capital and financial planning, which suits the subtraction decisions many systems now face. Closing a service line or exiting a market is a financial question with a strategic frame, and firms that treat the two as separate workstreams produce recommendations that the finance function then reopens.
May not be best if: You are a life sciences organization, or your question concerns commercial and go-to-market strategy.
6. Optum Advisory
Best for: Health systems moving into value-based arrangements and risk-bearing models.
Why it stands out: Optum Advisory brings scale and payer-side data to the transition toward value-based care, an area where understanding how risk arrangements behave in practice is worth more than modelling how they should. Its access to claims and population data at scale is a genuine analytical advantage in this specific domain.
May not be best if: Independence from payer interests matters to the decision. Optum is part of a payer organization, and for provider-side strategy where that alignment is material, the conflict is worth weighing explicitly.
7. Health Advances
Best for: Biotech, medical technology, and diagnostics organizations making commercial strategy decisions.
Why it stands out: Health Advances concentrates on life sciences commercial strategy with scientific depth alongside market analysis, which matters when a commercial question depends on whether a technology is genuinely differentiated. For diagnostics and medical technology in particular, that judgement is not separable from the science, and firms without it tend to produce market analysis resting on an unexamined clinical assumption.
May not be best if: You are a provider organization or payer, where life sciences commercial expertise does not transfer.
8. Simon-Kucher
Best for: Organizations where the strategic question is pricing, monetisation, or commercial model design.
Why it stands out: Simon-Kucher built its practice on pricing and commercial model work, and applies it across life sciences and health services. Pricing decisions in healthcare are constrained by payer behaviour, reimbursement pathways, and regulatory conditions in ways that general pricing practice does not accommodate, and the firm's healthcare work is built around those constraints rather than adapted to them.
May not be best if: Your question is operational, organizational, or concerns service delivery rather than commercial model.
9. Sg2
Best for: Health systems planning service capacity against forecast demand.
Why it stands out: Sg2 concentrates on healthcare market intelligence and demand forecasting, modelling how utilisation will shift across services and settings. Service line and capacity decisions rest on assumptions about future volume, and systems that make those decisions on internal extrapolation rather than modelled demand are the ones that build capacity into a declining service.
May not be best if: You need broad strategic advisory, transaction support, or work outside provider market planning.
10. West Monroe
Best for: Providers and payers wanting a strategy the same firm will then help implement.
Why it stands out: West Monroe combines strategic work with operational and technology delivery, staying through implementation rather than handing over a recommendation. In healthcare that continuity matters because strategies requiring system or workflow change are frequently abandoned at the point where somebody has to build them, and a partner already engaged is harder to stall.
May not be best if: You want a small senior team on a discrete strategic question, or analysis with no implementation relationship attached.
%20(1).png)
Let’s kickstart the conversation and design stuff people will love.
The Retail & Consumer Index
What Is Healthcare Strategy Consulting?
Healthcare strategy consulting is advisory work on consequential organizational decisions: which markets and services to compete in, how to structure a portfolio, how to price and position, and how to allocate capital across competing demands.
What separates it from strategy consulting elsewhere is the multiplicity of constraint. A decision must satisfy clinical viability, regulatory permission, payer economics, and community obligation simultaneously, and these frequently conflict. A service line that is financially unsustainable may be clinically necessary and politically impossible to close. Strategy work in this sector is therefore as much about which constraints are genuinely binding as about identifying the optimal answer.
How Does Healthcare Strategy Consulting Work?
Engagements typically run through diagnosis, option development, evaluation, and recommendation, with implementation planning included where it is in scope. Diagnosis establishes current position using market data, financial analysis, and stakeholder input. Options are developed and tested against financial, clinical, and regulatory feasibility.
The phase that determines whether the work matters is the one after it ends. Healthcare strategy has an unusually high rate of recommendations that are accepted and not executed, because execution requires clinical agreement, capital commitment, and organizational change that the strategy engagement did not secure. Firms that build the implementation path alongside the analysis, and involve the people who will have to act, produce a materially different rate of follow-through.
What Is a Healthcare Strategy Consulting Firm?
A healthcare strategy consulting firm advises healthcare organizations on market, portfolio, commercial, and capital decisions, combining sector knowledge with analytical method.
The category holds distinct models. Provider strategy firms work on health system market position and service portfolio. Life sciences strategy firms work on commercial and product questions. Actuarial firms work on risk and economics. Transaction advisers work to deal timetables. Pricing specialists work on monetisation. Market intelligence firms forecast demand. General healthcare experience predicts capability in any specific one of these poorly, which is why the first selection question is which model the decision requires.
What Services Do Healthcare Strategy Firms Provide?
Market and competitive strategy
Where to compete, against whom, and on what basis. Increasingly includes deciding where to stop competing, which the same analysis rarely addresses well.
Service line and portfolio strategy
Which clinical services to invest in, maintain, or exit. The decisions with the greatest financial consequence and the greatest internal resistance.
Growth and market entry
Geographic expansion, new service development, and partnership models, evaluated against demand forecasts rather than internal ambition.
Mergers, acquisitions, and affiliations
Target evaluation, due diligence, and integration planning. Integration is where value is lost and is the phase most often underscoped.
Commercial and pricing strategy
Pricing, contracting, and monetisation, constrained by payer behaviour and reimbursement pathways rather than willingness to pay alone.
Value-based care and risk strategy
Moving into arrangements where the organization carries financial risk for outcomes, which changes the economics of nearly everything else.
Capital allocation and financial strategy
Prioritising investment across facilities, technology, and services, where the constraint is usually capital rather than opportunity.
Demand forecasting and capacity planning
Modelling how utilisation will shift across services and settings, which determines whether capacity investment meets demand or misses it.
How Long Does a Healthcare Strategy Engagement Take?
A focused strategic question such as a service line assessment or market entry evaluation typically runs six to twelve weeks. A system-wide strategic plan or portfolio review generally runs three to six months. Transaction due diligence runs to the deal timetable, frequently four to eight weeks, regardless of what the analysis would ideally require.
Two variables move these ranges. Data availability, particularly market and competitor data, which in healthcare is fragmented and frequently incomplete outside the firm's own proprietary sources. And governance, since strategy work requiring board, clinical leadership, and community input moves at the pace of those calendars. Naming the decision-making body and its meeting schedule before the engagement begins does more for the timeline than any efficiency in the analysis.
How Healthcare Strategy Firms Price Their Work
Fixed fee against a defined scope is the norm. Transaction work is frequently priced to the deal timetable with premiums for compressed timelines. Market intelligence firms operate subscription models. Firms offering implementation typically price it separately from the strategy phase, which is worth establishing at the outset rather than discovering later.
The cost most often underestimated is primary research. Where a strategic question depends on physician, payer, or patient input, that research carries recruitment and incentive costs that can be significant, and proposals differ substantially in whether it is included and at what assumed sample.
The figure worth interrogating is the seniority mix. Healthcare strategy value comes disproportionately from judgement about which constraints bind, and that judgement sits with experienced people. Two proposals at similar rates can differ considerably in how much of the work those people actually do.
Why Hire a Healthcare Strategy Firm?
The strongest reason is comparative visibility. Internal teams see one organization's position in detail and competitors' positions through public information. A firm working across many comparable organizations knows which strategic moves have worked elsewhere and which have consistently disappointed.
The second is independence on decisions with internal losers. Closing a service line, exiting a market, or reallocating capital away from a respected programme is difficult to drive internally, and an external recommendation carries weight precisely because it is not attached to the organization's internal history.
The third is method under uncertainty. Healthcare decisions frequently rest on forecasts about policy, reimbursement, and utilisation that cannot be known, and firms with structured approaches to scenario analysis produce more defensible decisions than internal debate about which future is likelier.
How to Choose the Most Reliable Healthcare Strategy Firm
Start by naming which model the decision requires: provider strategy, life sciences commercial, actuarial, transaction, pricing, or market intelligence. Reputation transfers poorly between these, and the largest available firm is not the safer choice for a specialised question.
Then test three things. Independence, specifically whether the firm has commercial relationships that bear on the recommendation, which matters most where a firm is affiliated with a payer, vendor, or investor. Whether the analysis will be built to withstand challenge, since strategy that persuades is different from strategy that survives a hostile board question. And what happens after the recommendation, because acceptance without execution is the characteristic failure in this category.
One further question is worth asking. Ask what evidence would change their recommendation. A firm that can answer has a falsifiable position. A firm that cannot has an opinion dressed as analysis.
Decision Intelligence
15 Questions to Ask Before You Hire
1. What evidence would change your recommendation?
A firm that can answer holds a falsifiable position. One that cannot has an opinion presented as analysis.
2. Do you have commercial relationships that bear on this recommendation?
Payer, vendor, and investor affiliations are legitimate and should be visible before the advice, not after.
3. Which of our current services would you consider exiting?
Most strategy work is framed for growth. A firm willing to recommend subtraction is engaging with the actual decision.
4. Will this analysis survive a hostile board question?
Strategy that persuades and strategy that withstands challenge are different products.
5. What happens after the recommendation, and is implementation in scope?
Acceptance without execution is the characteristic failure in healthcare strategy. Settle it in the contract.
6. Which model are you: provider strategy, life sciences, actuarial, or transaction?
These are different businesses, and general healthcare credentials predict capability in a specific one poorly.
7. What market data will you use, and where does it come from?
Healthcare market data is fragmented. Proprietary sources are an advantage worth understanding and paying for.
8. Is primary research included, and at what assumed sample?
Physician and payer research carries real recruitment and incentive costs, and proposals differ on whether it is in scope.
9. How do you handle forecasts about policy and reimbursement?
Structured scenario work produces more defensible decisions than confident single-point predictions.
10. Who will do the work, and what share of their time is committed?
Value here comes from judgement about which constraints bind, and that sits with experienced people.
11. Which of your last three engagements were not implemented, and why?
A specific answer describes a real record. A claim of none describes a sales position.
12. How will you involve clinical leadership in developing options?
Recommendations clinicians have shaped get executed. Recommendations presented to them get debated.
13. What is the weakest part of your recommendation?
A firm that names it is being straight with you. One that claims none has not stress-tested its own work.
14. What will you need from our finance, clinical, and operational teams?
Internal bandwidth is the usual constraint on pace and the most commonly understated line in a proposal.
15. What would make you decline this engagement?
A firm with a clear answer knows where it adds value. No answer means it is describing capacity, not fit.
Why Choose G&CO.
G&CO. Health is the healthcare practice of G&CO., a global strategy and experience partner working with enterprise health systems, payers, and life sciences organizations. On strategy mandates we work where the recommendation has t reach the customer-facing business: market and portfolio analysis, the commercial position that follows from it, and the experience and digital work that makes the position real rather than stated. Strategy that stops at the deck is the characteristic outcome in this category, and building the delivery path alongside the analysis is what prevents it.
We are typically suited to enterprise healthcare organizations where a strategic decision implies changing what patients and clinicians encounter, and where the same partner is expected to help make that change rather than hand it over. Our Acumen decision intelligence platform supplies the market and behavioural evidence beneath the recommendation, supporting the segmentation and demand analysis that strategic choices depend on.
G&CO. Health is part of G&CO., a minority business enterprise (MBE), as certified by the National Minority Supplier Development Council (NMSDC). If diversity inclusion is part of your supplier process, we may be a strong fit for your enterprise.
Submit an inquiry to G&CO. Health on our contact page or click the blue Contact Us button on the bottom right of your screen.
